In a patent abstract filed October, 31 2012, Publication # US 8937050 B2, inventors from the Johns Hopkins University, Kennedy Krieger Institute, Inc., and not published until Jan 20, 2015, part of their proposed treatment of Autism involved a diet designed to restore viability to Mitochondria.
https://www.google.com/patents/US8937050
This week, in a double blind study to cure Congeintal Borreliosis, it has been found that the problem of Congenital Lyme Induced Regressive Autism was not the Mitochondria, but a total Thiocyanate Deficiency that allowed low grade inflammation of the the Superior Cervical Ganglion to block the nerve impulses going to the facial and vocal muscles controlling speech.
The B-Cell Neutrophils, being completely deficient in Thiocyanate to protect them from self-destruction by the oxidation process they use to kill bacteria and process vaccines, were not able to clear Borrelia induced inflammation of the Superior Cervical Ganglion, resulting in debilitation of the vocal apparatus.
In the two week pre-antibiotic dietary enhancement portion of the trial, it is becoming completely obvious to even the most casual observer that Autism is simply a symptom of Lyme Induced Thiocyanate Deficiency and not related to Mitochondrial debilitation.
The food supplements being sourced are non-GM and non-GMO food sources, available in the country where the trial participants are located and not supplied by their medical doctors prescribing the antibiotics, Monocycline and Tinidazole.
So...the question: Can a diet rich in non-GM and non-GMO sources of HMDB35030 be patented or not as a 'cure' for Congenital Lyme Induced Autism?
Comments rated to be "almost" Good Answers: